Close
ACHEMA MIDDLE EAST 2026

Agentic AI in Pharma: Transforming R&D to Commercialisation

The pharmaceutical industry is experiencing an unprecedented transformation driven by technological innovation and digital disruption. Among these technological advances, agentic Artificial Intelligence (AI) can...

The Future of Clinical Trial Data in Decentralisation Models

The landscape of clinical research is undergoing a seismic shift, powered by technological advancement, shifting patient expectations, and a worldwide drive for more effective...

Aptar Pharma Bolsters Clinical Trial Capabilities with Strategic Materials Manufacturing Acquisition

Aptar Pharma, a global leader in drug delivery and active material science solutions and services, announced its acquisition of the clinical trial materials manufacturing...

AI Revolutionizing Drug Discovery and Clinical Development

Artificial intelligence (AI) is no longer a solution to be theorized for drug discovery and clinical development, but rather a transformative tool that is changing...

Asia Pacific Omics-Based Clinical Trials Market Growth

The Asia Pacific Omics-based clinical trials market is expected to grow at a significant CAGR, owing to immense population diversity in Asia Pacific countries coupled...

Oracle Wins the Asia Pacific Biopharma Excellence Awards

Oracle Life Sciences has been felicitated with a couple of top honors at the 2025 Asia Pacific Biopharma Excellence Awards – ABEA. It is...

Bio-Rad to Acquire Stilla Technologies by Q3 2025

Bio-Rad Laboratories to Acquire Stilla Technologies to Expand Digital PCR Portfolio Stilla Technologies to Be Acquired by Bio-Rad Laboratories to Increase Digital PCR Portfolio A binding...

Subscribe Our Newsletter

White Papers

The Future of Digital Health

The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....

Five Best Practices to Deliver Exceptional Multichannel Experiences

A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...

The Impact and Use of Social Media in Pharmacovigilance

Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...